Results 111 to 120 of about 8,768 (188)

Absorption, excretion, and metabolism of the endothelin receptor antagonist bosentan in healthy male subjects

open access: yes, 1999
The absorption, excretion, and metabolism of the endothelin receptor antagonist bosentan was investigated in healthy male subjects by administration of 14C-labeled compound.
Weber, Cornelia   +2 more
core  

Activin A-Endothelin-1 Axis Governs Pulmonary Vascular Remodeling: Mechanistic Basis for Emerging Therapies in PAH. [PDF]

open access: yesArterioscler Thromb Vasc Biol
Faizah NN   +6 more
europepmc   +1 more source

Successful treatment of refractory chilblain lupus erythematosus with bosentan. [PDF]

open access: yesRheumatology (Oxford)
Gunawardana S   +3 more
europepmc   +1 more source

A K<sub>Ca</sub> 2.2/2.3 Opener Reverses ET-1-Induced NLRP3 Activation in Hypertensive Mice Corpora Cavernosa. [PDF]

open access: yesBiomolecules
Sobrano Fais R   +6 more
europepmc   +1 more source

Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes

open access: yes
Experimental evidence suggests that endothelin 1 (ET-1) is involved in the development of retinal microvascular abnormalities induced by diabetes. The effects of ET-1 are mediated by endothelin A- and B-receptors (ETA and ETB).
Hernández Pascual, Cristina   +13 more
core  

Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries. [PDF]

open access: yesJ Clin Med
Hirono K   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy